NCT00434590View on ClinicalTrials.gov

Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

Enteric coated mycophenolate sodium (Myfortic®)

Trial Locations (1)

Unknown

Novartis Investigative Site, Bologna

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00434590 - Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients | Biotech Hunter | Biotech Hunter